News

November 14, 2024

Eos leads £7.8m Series A into Naturbeads

November 11, 2024

Laverock makes significant advances in gene silencing platform

October 29, 2024

Novosound Develops World’s First Ultrasound Blood Pressure Monitor

October 28, 2024

Wobble announce breast cancer study at San Francisco conference

October 1, 2024

Chemify land significant grant from Gates Foundation

September 26, 2024

Laverock makes significant advances

All News

Eos leads £7.8m Series A into Naturbeads

November 14, 2024

Laverock makes significant advances in gene silencing platform

November 11, 2024

Novosound Develops World’s First Ultrasound Blood Pressure Monitor

October 29, 2024

Wobble announce breast cancer study at San Francisco conference

October 28, 2024

Chemify land significant grant from Gates Foundation

October 1, 2024

Laverock makes significant advances

September 26, 2024

Mark Beaumont in conversation on the Hardman podcast

August 6, 2024

Carcinotech and Ishani win top awards at EISA

June 21, 2024

Nami Surgical secures £3.2 million led by Eos

May 12, 2024

Dxcover present clinical trial for the early detection of cancer at the American Association for Cancer Research

April 9, 2024

Neupulse secures a £2.5 million investment led by Eos

March 18, 2024

Pathways Pledge Launch

February 29, 2024

Discover

Contact

Eos Advisory LLP,
Kinburn Castle,
Doubledykes Road,
St Andrews, KY16 9DR

Eos Advisory LLP is a Limited Liability Partnership registered in Scotland with registered number SO306577. Registered Office: Kinburn Castle, Doubledykes Road, St Andrews, KY16 9DR. Eos Advisory LLP is authorised and regulated by the Financial Conduct Authority (FCA), reference number 980583.

News

November 14, 2024

Eos leads £7.8m Series A into Naturbeads

November 11, 2024

Laverock makes significant advances in gene silencing platform

October 29, 2024

Novosound Develops World’s First Ultrasound Blood Pressure Monitor

October 28, 2024

Wobble announce breast cancer study at San Francisco conference

October 1, 2024

Chemify land significant grant from Gates Foundation

September 26, 2024

Laverock makes significant advances

All News

November 14, 2024

Read more

November 11, 2024

Read more

October 29, 2024

Read more

October 28, 2024

Read more

October 1, 2024

Read more

September 26, 2024

Read more

August 6, 2024

Read more

June 21, 2024

Read more

May 12, 2024

Read more

April 9, 2024

Read more

March 18, 2024

Read more

February 29, 2024

Read more

Discover

Links

Contact

© Eos Advisory LLP,

2024

| All rights reserved

Latest news

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.